Given this overlap in inflammatory response between HS and DM, it is interesting to consider whether commonly employed anti-inflammatory therapy for HS, for example with TNF-α inhibitors, also leads to an improvement of the hyperglycemic metabolic situation. The gene discussed is TNF; the disease is diabetes mellitus.